Lowell Schnipper

Dr. Schnipper is the immediate past Clinical Director of the Cancer Center and Chief, Division of Hematology/Oncology at the Beth Israel Deaconess Medical Center and the Theodore W. and Evelyn G. Berenson Distinguished Professor of Medicine in the field of Oncology at Harvard Medical School. He is the Associate Director of the Dana-Farber/Harvard Cancer Center for membership, and a member of its executive committee. Dr. Schnipper received his M.D. from the State University of New York Downstate College of Medicine, summa cum laude, and prior to joining the BIDMC, trained at the Yale New Haven Medical Center, the National Cancer Institute, and Washington University. In addition to his clinical work and teaching, Dr. Schnipper is deeply committed to oncology research, having been the recipient of numerous peer-reviewed grants over the years from the National Cancer Institute and American Cancer Society. He research has contributed to our understanding of the mechanism of action of anti-viral and anti-neoplastic therapies, genomic instability in cancer, and more recently, quality and value in cancer care. At the Beth Israel Deaconess Medical Center Dr. Schnipper and colleagues built an innovative hematology-oncology clinical training program, complemented by a translational research program centered on translating advances in cancer biology to improvements in patient care. Dr. Schnipper has a long commitment to health care policy and medical ethics. He has been a member of the Board of Directors of the American Cancer Society and president of its Massachusetts Division. He is the recipient of the St. George Medal from the American Cancer Society and a Distinguished Service Award and Special Recognition Award from the American Society of Clinical Oncology (ASCO). Dr. Schnipper has held numerous leadership positions in ASCO including Chairmanships of the Cancer Research, Ethics and Public Issues Committees, and currently serves as the Chairman of the ASCO Task Force on the Value of Cancer Care. Dr. Schnipper’s professional interests extend to Global Oncology. Since 2011 he has collaborated with NGO’s committed to supporting health care in under-resourced nations. These initiatives include a collaboration with two mission hospitals in rural Zimbabwe focused on prevention of cervical cancer. As of this date more than 19,000 women have been screened for this disease, many hundreds found to harbor pre-malignant lesions and treated accordingly. This work has also enabled replacement/refurbishment of needed equipment and upgrading infrastructure at the St. Albert’s Mission Hospital.

EDUCATIONAL TITLES

• Theodore W. and Evelyn G. Berenson Professor, Medicine, Harvard Medical School
• Chief, Hematology/Oncology, Beth Israel Deaconess Medical Center
• Clinical Director, Beth Israel Deaconess Medical Center Cancer Center, Beth Israel Deaconess Medical Center

DF/HCC PROGRAM AFFILIATION

• Breast Cancer, Member
• Developmental Therapeutics, Member

DF/HCC ASSOCIATIONS

• Institutional Representative for BIDMC, Membership Committee
• Member, Clinical Science Coordinating Committee
• Member, Center Scientific Council
• Chair, Membership Committee
• Associate Director, Membership, Executive Committee

Publications

• Fish M, Parkes J, Dharsee N, Dryden-Peterson S, Efstathiou J, Schnipper L, Chabner B, Parikh AR. POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa. Oncologist 2019. PubMed
• Willke RJ, Chapman RH, Seidman JJ, Schnipper LE, Gleason PP. Current Value Frameworks-What's New? Value Health 2019; 22:S7-S11. PubMed
• Borno H, George DJ, Schnipper LE, Cavalli F, Cerny T, Gillessen S. All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care. Am Soc Clin Oncol Educ Book 2019; 39:302-308. PubMed
• Hortobagyi GN, Pyle D, Cazap EL, El Saghir NS, Shulman LN, Lyman GH, Schnipper LE, Adebamowo CA, Gandara DR, Vose J, Wong SL, Yu P. American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions. J Glob Oncol 2018. PubMed
• Jazieh AR, Al-Saggabi AH, McClung M, Carlson R, Schnipper LE, Eniu A, Blauvelt B, Zafar Y, Kerr D. Facing the Global Challenges of Access to Cancer Medication. J Glob Oncol 2018. PubMed
• Schnipper LE, Schilsky RL. Are Value Frameworks Missing the Mark When Considering Long-term Benefits From Immuno-oncology Drugs? JAMA Oncol 2017. PubMed
• Schilsky RL, Schnipper LE. Hans Christian Andersen and the Value of New Cancer Treatments. Journal of the National Cancer Institute 2017. PubMed
• Schnipper LE. Direct-to-consumer advertising of cancer treatments. Clin Adv Hematol Oncol 2017; 15:748-750. PubMed
• Schnipper LE, Schilsky RL. Converging on the Value of Value Frameworks. J Clin Oncol 2017. PubMed
• Schnipper LE, Abel GA. Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health. JAMA Oncol 2016. PubMed
• Schnipper LE, Bastian A. New Frameworks to Assess Value of Cancer Care: Strengths and Limitations. Oncologist 2016; 21:654-8. PubMed
• Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol 2016. PubMed
• Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL, American Society of Clinical Oncology. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol 2015. PubMed
• Schnipper LE, Meropol NJ. Payment for cancer care: time for a new prescription. J Clin Oncol 2014; 32:4027-8. PubMed
• Schnipper LE. Quality oncology practice initiative: an approach to solving the value equation. J Oncol Pract 2014; 10:219-20. PubMed
• Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol 2014; 32:1277-80. PubMed
• Shih YC, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, Goodwin JS, Hu JC, Schrag D, Temel JS, Schnipper L. Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol 2013; 31:4151-7. PubMed
• Schnipper LE. The rising cost of cancer care: physicians take charge. J Oncol Pract 2012; 8:e87-8. PubMed
• Peppercorn JM, Smith TJ, Helft PR, Debono DJ, Berry SR, Wollins DS, Hayes DM, Von Roenn JH, Schnipper LE, . American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 2011; 29:755-60. PubMed
• Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, . American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009; 27:3868-74. PubMed
• Schnipper LE. Update in oncology. Ann Intern Med 2007; 147:775-82. PubMed
• Miksad RA, Schnipper L, Goldstein M. Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value? J Clin Oncol 2007; 25:4506-7; author reply 4508. PubMed
• Pentz RD, Joffe S, Emanuel EJ, Schnipper LE, Haskell CM, Tannock IF. ASCO core values. J Clin Oncol 2006; 24:5780-2. PubMed